Study of Recombinant Human Thrombin for Bleeding During Surgery
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether recombinant human Thrombin (rhThrombin) is
effective in stopping bleeding during surgery, in comparison with bovine thrombin.